US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 28.750
  • +0.450+1.59%
Close Jul 22 16:00 ET
  • 28.750
  • 0.0000.00%
Post 16:22 ET
3.57BMarket Cap-6796P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arrowhead Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

May 9, 2024

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-1.02

-326.67%
Analyst Rating

Buy

Jul 5, 2024

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q4-- / 38.916M--
--2024/Q3-- / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--
--2024/Q13.551M / 29.636M--
Nov 29, 20232023/Q416.097M / 46.967M--
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q4-- / 38.916M--
--2024/Q3-- / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--
--2024/Q13.551M / 29.636M--
Nov 29, 20232023/Q416.097M / 46.967M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

  • Arrowhead Pharmaceuticals | 10-Q: Quarterly report

    May 9 16:18 ET

  • Arrowhead Pharmaceuticals | 10-Q: Quarterly report

    Feb 6 16:19 ET

  • Arrowhead Pharmaceuticals: FY2023 Annual Report

    Nov 29, 2023 16:09 ET

  • Arrowhead Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Aug 7, 2023 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 5, 2024

    Buy

    • Buy

      63.64%

    • Hold

      36.36%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg